We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$672M
AUM Growth
+$54.8M
Cap. Flow
+$50.6M
Cap. Flow %
7.53%
Top 10 Hldgs %
35.69%
Holding
5,893
New
1,202
Increased
1,600
Reduced
1,403
Closed
1,568

Sector Composition

Rank Sector Weight
1 Technology 5.35%
2 Consumer Discretionary 3.08%
3 Materials 2.71%
4 Industrials 2.51%
5 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YVR
3826
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$1K ﹤0.01%
26
+25
+2,500% +$1.06K
ACGN
3827
DELISTED
Aceragen Inc
ACGN
$1K ﹤0.01%
2
-13
-87% -$3.47K
TA
3828
DELISTED
TravelCenters of America LLC
TA
$1K ﹤0.01%
22
-404
-95% -$15.6K
NVCN
3829
DELISTED
Neovasc Inc.
NVCN
0
AGRX
3830
DELISTED
Agile Therapeutics
AGRX
-1
Closed -$12.9K
SIOX
3831
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
15
-121
-89% -$12.9K
IVH
3832
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
$1K ﹤0.01%
+100
New +$1.18K
REED
3833
DELISTED
Reeds, Inc. Common Stock
REED
$1K ﹤0.01%
+4
New +$996
AHPI
3834
DELISTED
Allied Healthcare Products
AHPI
$1K ﹤0.01%
813
-249
-23% -$395
HTGM
3835
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$1K ﹤0.01%
1
-1
-50% -$559
MN
3836
DELISTED
MANNING & NAPIER, INC.
MN
$1K ﹤0.01%
82
-1,292
-94% -$9.52K
MANT
3837
DELISTED
Mantech International Corp
MANT
$1K ﹤0.01%
35
-65
-65% -$1.9K
ACH
3838
DELISTED
Alum Corp of China Ltd
ACH
$1K ﹤0.01%
+183
New +$1.48K
EPZM
3839
DELISTED
Epizyme, Inc
EPZM
$1K ﹤0.01%
95
-1,769
-95% -$17.9K
OBCI
3840
DELISTED
Ocean Bio-Chem Inc
OBCI
$1K ﹤0.01%
+259
New +$567
MYJ
3841
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
$1K ﹤0.01%
65
-317
-83% -$5.08K
MFL
3842
DELISTED
BLACKROCK MUNIHOLDINGS INVESTMENT QUALITY FUND
MFL
$1K ﹤0.01%
+43
New +$641
RESN
3843
DELISTED
Resonant Inc.
RESN
$1K ﹤0.01%
433
+9
+2% +$20
ARNA
3844
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1K ﹤0.01%
25
-450
-95% -$7.21K
PVG
3845
DELISTED
PRETIUM RESOURCES INC.
PVG
$1K ﹤0.01%
254
-1,110
-81% -$5.48K
ACBI
3846
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$1K ﹤0.01%
+45
New +$598
NXQ
3847
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
$1K ﹤0.01%
100
-120
-55% -$1.68K
XLRN
3848
DELISTED
Acceleron Pharma
XLRN
$1K ﹤0.01%
+20
New +$582
BOCH
3849
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$1K ﹤0.01%
168
+45
+37% +$277
EXFO
3850
DELISTED
EXFO INC.
EXFO
$1K ﹤0.01%
300
-603
-67% -$1.83K

Similar funds

Tower Research Capital (TRC)'s Q1 2016 Portfolio in Review

As of Q1 2016, Tower Research Capital (TRC) held 5,893 positions worth $672M, up 8.9% from $617M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $50.6M of net new capital in Q1 2016, opening 1,202 new positions and adding to 1,600 existing holdings. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 287,194 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 1.4% a quarter earlier, followed by Consumer Discretionary and Materials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $227M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2016 buy was State Street Industrial Select Sector SPDR ETF: 287,194 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2016, an estimated $52.3M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $227M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P 500 ETF in Q1 2016, selling an estimated $9.03M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $672M portfolio in Q1 2016.
  • Tower Research Capital (TRC) opened 1,202 new positions and closed 1,568 in Q1 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 8.9% quarter-over-quarter to $672M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2016, filed 16 May 2016.